Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Effectiveness and Tolerability of First-Line Afatinib for Advanced EGFR-Mutant Non-Small Cell Lung Cancer in Vietnam.

Autor: Vu TH; Department of Medical Oncology, Vietnam National Cancer Hospital, Hanoi, Vietnam., Nguyen HTT; Department of Medical Oncology, Vietnam National Cancer Hospital, Hanoi, Vietnam.; Department of Oncology, Vietnam University of Traditional Medicine, Hanoi, Vietnam., Dao LK; Department of Medical Oncology, Vietnam National Cancer Hospital, Hanoi, Vietnam., Duong CK; Department of Medical Oncology, Vietnam National Cancer Hospital, Hanoi, Vietnam., Nguyen CV; Department of Medical Oncology, Vietnam National Cancer Hospital, Hanoi, Vietnam., Doan TT; Department of Medical Oncology, Vietnam National Cancer Hospital, Hanoi, Vietnam., Nguyen HTT; Department of Medical Oncology, Vietnam National Cancer Hospital, Hanoi, Vietnam., Hoang HH; Department of Medical Oncology, Vietnam National Cancer Hospital, Hanoi, Vietnam.; Department of Oncology, Hanoi Medical University, Hanoi, Vietnam., Dinh DK; Department of Medical Oncology, Vietnam National Cancer Hospital, Hanoi, Vietnam., Le GV; Department of Medical Oncology, Vietnam National Cancer Hospital, Hanoi, Vietnam., Vu TT; Department of Medical Oncology, Vietnam National Cancer Hospital, Hanoi, Vietnam., Truong MC; Department of Oncology, Hanoi Medical University, Hanoi, Vietnam., Nguyen LT; Department of Oncology, Hanoi Medical University, Hanoi, Vietnam.

Publikováno v: Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2021 May 01; Vol. 22 (5), pp. 1581-1590. Date of Electronic Publication: 2021 May 01.